“…Therefore, results from social pharmacology studies such as those reviewed here have implications for a range of clinical outcomes marked by social withdrawal, feelings of social disconnection, and other social deficits (e.g., depression; Panksepp, Wright, Dobrossy, Schlaepfer, & Coenen, 2014). Social factors are also emerging as key contributors to the entire trajectory of disease, from identifying those at risk (e.g., Slavich & Irwin, 2014), to estimating the progression of disease (e.g., Lutgendorf & Sood, 2011), to predicting recovery (e.g., Heilig et al, 2016). Opioids should be considered among other healthrelated pathways in the body (e.g., inflammation; Eisenberger, Moieni, Inagaki, Muscatell, & Irwin, 2017) to better understand how social interactions affect health outcomes.…”